PMID: 11331404May 2, 2001Paper

Protein kinase C-mediated functional regulation of dopamine transporter is not achieved by direct phosphorylation of the dopamine transporter protein

Journal of Neurochemistry
M Y ChangY S Lee

Abstract

Dopaminergic neurotransmission is terminated by the action of the presynaptic dopamine transporter (DAT). It mediates Na(+)/Cl(-) -dependent re-uptake of extracellular dopamine (DA) into the cell, and is regarded as a major regulatory mechanism for synaptic transmission. Previous works have documented that protein kinase C (PKC) activator or inhibitor alters DA uptake by DAT, suggesting that PKC phosphorylation plays an important regulatory mechanism in DAT function. Based on the existence of consensus amino acid sequences for PKC phosphorylation, it has been postulated that PKC regulation of DAT is mediated by the direct phosphorylation of DAT protein. In this study, we try to discover whether the functional regulation of DAT by PKC is due to direct phosphorylation of DAT. The PKC null mutant hDAT, where all putative PKC phosphorylation sites are eliminated, has been constructed by the replacement of serine/threonine residues with glycines. The mutation itself showed no effect on the functional activities of DAT. The DA uptake activity of PKC null mutant was equivalent to those of wild-type hDAT (80-110% of wild-type). Phorbol ester activation of PKC inhibited DA uptake of wild-type hDAT by 35%, and staurosphorine blocked the ...Continue Reading

References

Dec 1, 1992·Trends in Pharmacological Sciences·G R Uhl, P R Hartig
Dec 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·T B UsdinB J Hoffman
Sep 1, 1990·Trends in Biochemical Sciences·B E Kemp, R B Pearson
Jul 15, 1994·European Journal of Pharmacology·S KitayamaG R Uhl
Jan 1, 1993·Annual Review of Neuroscience·S G Amara, M J Kuhar
Feb 1, 1994·Proceedings of the National Academy of Sciences of the United States of America·J L CoreyJ Guastella
Feb 1, 1993·Trends in Pharmacological Sciences·B Giros, M G Caron
Jan 27, 1998·The Journal of Biological Chemistry·S RamamoorthyR D Blakely
May 24, 2000·Proceedings of the National Academy of Sciences of the United States of America·C SaundersA Galli

❮ Previous
Next ❯

Citations

Feb 3, 2005·Pflügers Archiv : European journal of physiology·Giuliano Ciarimboli, Eberhard Schlatter
Nov 13, 2003·European Journal of Pharmacology·Margaret E Gnegy
Nov 13, 2003·European Journal of Pharmacology·Joshua M Gulley, Nancy R Zahniser
Nov 13, 2003·European Journal of Pharmacology·Ole V Mortensen, Susan G Amara
Jan 17, 2009·Biochemistry·Balachandra K GorentlaRoxanne A Vaughan
Feb 6, 2010·The Journal of Biological Chemistry·D Nicole Riherd Methner, R Dayne Mayfield
Jan 8, 2011·The Journal of Biological Chemistry·Arnau Vina-VilasecaAlexander Sorkin
Nov 20, 2012·The Journal of Biological Chemistry·Amy E MoritzRoxanne A Vaughan
Dec 23, 2008·The Journal of Pharmacology and Experimental Therapeutics·Rong ChenMargaret E Gnegy
Nov 5, 2002·Annual Review of Pharmacology and Toxicology·Richard Nass, Randy D Blakely
May 8, 2009·Molecular Brain·Heping ZhangFang Liu
May 4, 2016·Basal Ganglia·David SulzerMargaret E Rice
Dec 4, 2009·Biochemical Pharmacology·Ching-I Anderson Wang, Richard J Lewis
Mar 6, 2010·Annals of the New York Academy of Sciences·Kyle C Schmitt, Maarten E A Reith
Oct 27, 2004·Pharmacology & Therapeutics·Haley E Melikian
Mar 30, 2016·Neurochemistry International·Anne VuorenpääUlrik Gether
Jan 19, 2006·Neurochemistry International·Massimiliano G BianchiOvidio Bussolati
Jun 12, 2012·European Journal of Pharmacology·Dove J KeithAaron Janowsky
Apr 5, 2013·PloS One·Jennie Garcia-OlivaresGonzalo E Torres
Sep 4, 2016·Pharmacological Reviews·Daniel P Bermingham, Randy D Blakely
Oct 8, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·George R Uhl
May 8, 2002·The Journal of Biological Chemistry·James D FosterRoxanne A Vaughan
Jun 19, 2002·The Journal of Biological Chemistry·Rajani MaiyaR Dayne Mayfield
Jan 4, 2003·Nature Reviews. Neuroscience·Gonzalo E TorresMarc G Caron
Jul 17, 2009·American Journal of Physiology. Cell Physiology·Valeria PadovanoGrazia Pietrini
Mar 22, 2002·The Journal of Pharmacology and Experimental Therapeutics·Alicia E DerbezLinda L Werling
Sep 27, 2015·Pharmacological Reviews·Christopher L GermanAnnette E Fleckenstein
Sep 17, 2003·The Journal of Pharmacology and Experimental Therapeutics·Limen Chi, Maarten E A Reith
Apr 6, 2004·The Journal of Pharmacology and Experimental Therapeutics·Roxanne A Vaughan
Jul 15, 2011·Pharmacological Reviews·Anders S KristensenUlrik Gether
Jun 7, 2015·The Journal of Biological Chemistry·Stéphanie De GoisBruno Giros
Jul 23, 2003·Journal of the American Society of Nephrology : JASN·Natascha A WolffGerhard Burckhardt
May 1, 2021·Frontiers in Cellular Neuroscience·Renae M RyanAnnalisa Scimemi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.